Doxazosin and DZ-50 were both found to exert potent antitumor action against human renal cancer cell lines 786-0 (harboring a VHL tumor-suppressor gene mutation and a highly angiogenic phenotype) and Caki cells (without a VHL mutation) [3]. The gene discussed is VHL; the disease is neoplasm.